HOME ABOUT US RESEARCH INTO PRACTICE OUTREACH
If you require any information about the research project please contact Caroline Calvert (email@example.com). Inquiries related to commercial seed purchase should be directed to Michael McDaniel at East-West Seed International (Michael.McDaniel@eastwestseed.com).
Further information about CNAP hybrids can be found on a dedicated website: www.ArtemisiaF1seed.org
CNAP Artemisia Research Project
Update, October 2013.
The CNAP Artemisia Research Project has successfully developed new hybrid varieties of the medicinal plant Artemisia annua; the primary source of the leading anti-malarial drug artemisinin.
We have two hybrid varieties that can now be purchased in large quantities from East-West Seed International, our commercialisation partner. East-West Seed are market leaders in breeding and commercialising hybrid seeds throughout Asia and their expertise in field-based seed production means that seed supplies are sustainable and can be purchased at a very competitive price.
Our research has provided a major resource of information on A. annua and we are continuing to study the biology and agronomy of this important plant. We are grateful to the Bill & Melinda Gates Foundation for their continued financial support for our research and development programme on A. annua. The ongoing work in CNAP with East-West Seed will ensure continued improvement of hybrids and a sustainable delivery of A. annua hybrids to market.
In addition, we are actively pursuing the development of a technology platform using A. annua as a production system for new, biologically-active molecules. This is an exciting area of research and will significantly contribute to our industrial biotechnology programme in CNAP.
Professor Ian Graham,
Department of Biology